« On Pfizer's New HIV Therapy | Main | Vegas Bleg »



You are misleading on so many counts, it’s really sad.

First off, you don’t have to trawl through SEC fillings to know the company has been buying back stock: they talk about it on conference calls every quarter that it happens. They have been doing it for the last two years. This isn’t news.

Second, you didn’t put up a five-year chart of EXBD against the market. If you had invested in EXBD then, you’d still be well ahead today.

Third, the company’s growth rate is still above that of its peer group and many of those in the market. Period.

Fourth, investing is a long-term thing. If you have a one-year time horizon, stick to a money market account or a CD. Stocks can take a beating, get over it.

That said, you are right on one thing, EXBD does have a pretty boring name.

The comments to this entry are closed.

What is This?

  • The Stalwart is a blog written by Joseph Weisenthal, covering such topics as stocks, business, economics, politics, technology, gambling, chess, poker, economics, current events, music, math, Chinese food, science, randomness, kurtosis, sports, evolutionary fitness, and anything else of the author's choosing. The words contained herein are the author's own, not affiliated with any other firm or employer.